CSNB1E
MCID: NGH029
MIFTS: 37

Night Blindness, Congenital Stationary, Type 1e (CSNB1E)

Categories: Eye diseases, Genetic diseases, Mental diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Night Blindness, Congenital Stationary, Type 1e

MalaCards integrated aliases for Night Blindness, Congenital Stationary, Type 1e:

Name: Night Blindness, Congenital Stationary, Type 1e 56 71
Night Blindness, Congenital Stationary , 1e, Autosomal Recessive 56 29 13
Csnb1e 56 12 73
Congenital Stationary Night Blindness, Type 1e 29 6
Congenital Stationary Night Blindness 1e Autosomal Recessive 12
Blindness, Night, Stationary, Congenital, Type 1e 39
Night Blindness, Congenital Stationary, 1e 73
Congenital Stationary Night Blindness 1e 12
Csnb, Complete, Autosomal Recessive 56
Complete Autosomal Recessive Csnb 73
Csnb1 54

Characteristics:

OMIM:

56
Inheritance:
autosomal recessive


HPO:

31
night blindness, congenital stationary, type 1e:
Inheritance autosomal recessive inheritance x-linked recessive inheritance


Classifications:



External Ids:

Disease Ontology 12 DOID:0110869
OMIM 56 614565
OMIM Phenotypic Series 56 PS310500
MeSH 43 D009755
MedGen 41 C3281215
UMLS 71 C3281215

Summaries for Night Blindness, Congenital Stationary, Type 1e

OMIM : 56 Complete congenital stationary night blindness (cCSNB) is a clinically and genetically heterogeneous group of retinal disorders characterized by nonprogressive impairment of night vision, absence of the electroretinogram (ERG) b-wave, and variable degrees of involvement of other visual functions. Individuals with cCSNB and animal models of the disorder have an ERG waveform that lacks the b-wave because of failure to transmit the photoreceptor signal through the retinal depolarizing bipolar cells (summary by Peachey et al., 2012). For a general phenotypic description and a discussion of genetic heterogeneity of congenital stationary night blindness, see CSNB1A (310500). (614565)

MalaCards based summary : Night Blindness, Congenital Stationary, Type 1e, also known as night blindness, congenital stationary , 1e, autosomal recessive, is related to night blindness, congenital stationary, type 1b and night blindness, congenital stationary, type 1a. An important gene associated with Night Blindness, Congenital Stationary, Type 1e is GPR179 (G Protein-Coupled Receptor 179). Affiliated tissues include retina and eye, and related phenotypes are strabismus and nystagmus

Disease Ontology : 12 A congenital stationary night blindness characterized by autosomal recessive inheritance that has material basis in homozygous or compound heterozygous mutation in the GPR179 gene on chromosome 17q12.

UniProtKB/Swiss-Prot : 73 Night blindness, congenital stationary, 1E: An autosomal recessive, non-progressive retinal disorder characterized by impaired night vision, absence of the electroretinogram (ERG) b- wave, and variable degrees of involvement of other visual functions. Affected individuals have an ERG waveform that lacks the b-wave because of failure to transmit the photoreceptor signal through the retinal depolarizing bipolar cells.

Related Diseases for Night Blindness, Congenital Stationary, Type 1e

Diseases in the Congenital Stationary Night Blindness family:

Night Blindness, Congenital Stationary, Autosomal Dominant 2 Night Blindness, Congenital Stationary, Type 1b
Night Blindness, Congenital Stationary, Type 2a Night Blindness, Congenital Stationary, Type 1a
Night Blindness, Congenital Stationary, Autosomal Dominant 3 Night Blindness, Congenital Stationary, Autosomal Dominant 1
Night Blindness, Congenital Stationary, Type 1c Night Blindness, Congenital Stationary, Type 1d
Night Blindness, Congenital Stationary, Type 1e Night Blindness, Congenital Stationary, Type 1f
Night Blindness, Congenital Stationary, Type 1g Night Blindness, Congenital Stationary, Type 1h
Autosomal Dominant Congenital Stationary Night Blindness Autosomal Recessive Congenital Stationary Night Blindness

Diseases related to Night Blindness, Congenital Stationary, Type 1e via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 29)
# Related Disease Score Top Affiliating Genes
1 night blindness, congenital stationary, type 1b 32.0 NYX GPR179
2 night blindness, congenital stationary, type 1a 31.2 NYX GPR179 CACNA1F
3 night blindness, congenital stationary, type 1c 31.1 NYX GPR179 CACNA1F
4 congenital stationary night blindness 31.1 NYX NLRP12 GPR179 CACNA1F
5 night blindness 29.7 NYX GPR179 CACNA1F
6 night blindness, congenital stationary, type 2a 29.6 NYX CACNA1F
7 achromatopsia 29.5 NYX CACNA1F
8 myopia 29.5 NYX CACNA1F
9 x-linked congenital stationary night blindness 29.4 NYX NLRP12 CACNA1F
10 night blindness, congenital stationary, type 1d 11.5
11 night blindness, congenital stationary, type 1f 11.5
12 nystagmus 1, congenital, x-linked 11.2
13 yemenite deaf-blind hypopigmentation syndrome 10.5
14 joint laxity, short stature, and myopia 10.3
15 keratoconus 10.3
16 myopia 1, x-linked 10.1
17 astigmatism 10.1
18 irregular astigmatism 10.1
19 hereditary retinal dystrophy 10.1
20 abnormal threshold of rods 9.7 GPR179 CACNA1F
21 cone-rod dystrophy, x-linked, 3 9.6 NYX CACNA1F
22 achromatopsia 3 9.6 NYX CACNA1F
23 oguchi disease 9.5 NYX CACNA1F
24 aland island eye disease 9.5 NYX CACNA1F
25 retinoschisis 1, x-linked, juvenile 9.5 NYX CACNA1F
26 pathologic nystagmus 9.4 NYX CACNA1F
27 retinal disease 9.4 NYX CACNA1F
28 fundus dystrophy 9.1 NYX GPR179 CACNA1F
29 retinitis pigmentosa 8.8 NYX GPR179 CACNA1F

Graphical network of the top 20 diseases related to Night Blindness, Congenital Stationary, Type 1e:



Diseases related to Night Blindness, Congenital Stationary, Type 1e

Symptoms & Phenotypes for Night Blindness, Congenital Stationary, Type 1e

Human phenotypes related to Night Blindness, Congenital Stationary, Type 1e:

31
# Description HPO Frequency HPO Source Accession
1 strabismus 31 occasional (7.5%) HP:0000486
2 nystagmus 31 HP:0000639
3 myopia 31 HP:0000545
4 reduced visual acuity 31 HP:0007663
5 congenital stationary night blindness 31 HP:0007642

Symptoms via clinical synopsis from OMIM:

56
Head And Neck Eyes:
decreased visual acuity
strabismus (in some patients)
night blindness, congenital
absent or reduced b-wave on electroretinography
myopia, mild to severe
more

Clinical features from OMIM:

614565

Drugs & Therapeutics for Night Blindness, Congenital Stationary, Type 1e

Search Clinical Trials , NIH Clinical Center for Night Blindness, Congenital Stationary, Type 1e

Genetic Tests for Night Blindness, Congenital Stationary, Type 1e

Genetic tests related to Night Blindness, Congenital Stationary, Type 1e:

# Genetic test Affiliating Genes
1 Congenital Stationary Night Blindness, Type 1e 29 GPR179
2 Night Blindness, Congenital Stationary (complete), 1e, Autosomal Recessive 29

Anatomical Context for Night Blindness, Congenital Stationary, Type 1e

MalaCards organs/tissues related to Night Blindness, Congenital Stationary, Type 1e:

40
Retina, Eye

Publications for Night Blindness, Congenital Stationary, Type 1e

Articles related to Night Blindness, Congenital Stationary, Type 1e:

(show top 50) (show all 64)
# Title Authors PMID Year
1
Whole-exome sequencing identifies mutations in GPR179 leading to autosomal-recessive complete congenital stationary night blindness. 6 56
22325361 2012
2
GPR179 is required for depolarizing bipolar cell function and is mutated in autosomal-recessive complete congenital stationary night blindness. 6 56
22325362 2012
3
Scotopic threshold response in complete and incomplete types of congenital stationary night blindness. 56
8088964 1994
4
Mutations in NYX of individuals with high myopia, but without night blindness. 61 54
17392683 2007
5
Localization of nyctalopin in the mammalian retina. 54 61
16553780 2006
6
Isolation and characterization of the leucine-rich proteoglycan nyctalopin gene (cNyx) from chick. 54 61
16261423 2005
7
Multifocal oscillatory potentials in CSNB1 and CSNB2 type congenital stationary night blindness. 54 61
15583843 2005
8
Primate Retinal Signaling Pathways: Suppressing ON-Pathway Activity in Monkey With Glutamate Analogues Mimics Human CSNB1-NYX Genetic Night Blindness. 54 61
15331616 2005
9
NYX (nyctalopin on chromosome X), the gene mutated in congenital stationary night blindness, encodes a cell surface protein. 54 61
14507859 2003
10
Isolation of the mouse nyctalopin gene nyx and expression studies in mouse and rat retina. 54 61
12714669 2003
11
[Establishment of the concept of new clinical entities--complete and incomplete form of congenital stationary night blindness]. 54 61
12610835 2002
12
Phenotypic expression of the complete type of X-linked congenital stationary night blindness in patients with different mutations in the NYX gene. 54 61
12397430 2002
13
Slow and fast rod ERG pathways in patients with X-linked complete stationary night blindness carrying mutations in the NYX gene. 61 54
11581222 2001
14
Case populations must match the respective disease model: Genotype diversity causes linkage disequilibrium mapping failure in monogenic disorders. 54 61
11408949 2001
15
Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindness. 61 54
11062471 2000
16
[Multimodal diagnostic of CSNB1 with NYX gene mutation]. 61
30980176 2019
17
Long-Term Clinical Course in a Patient with Complete Congenital Stationary Night Blindness. 61
28512427 2017
18
Novel TRPM1 mutations in two Chinese families with early-onset high myopia, with or without complete congenital stationary night blindness. 61
27803854 2016
19
Intravitreal delivery of a novel AAV vector targets ON bipolar cells and restores visual function in a mouse model of complete congenital stationary night blindness. 61
26310623 2015
20
NYX mutations in four families with high myopia with or without CSNB1. 61
25802485 2015
21
Sorting out co-occurrence of rare monogenic retinopathies: Stargardt disease co-existing with congenital stationary night blindness. 61
24397708 2014
22
Ultrastructural localization of GPR179 and the impact of mutant forms on retinal function in CSNB1 patients and a mouse model. 61
24084093 2013
23
Genotype and phenotype of 101 dutch patients with congenital stationary night blindness. 61
23714322 2013
24
Assessment of night vision problems in patients with congenital stationary night blindness. 61
23658786 2013
25
An extended 15 Hz ERG protocol (2): data of normal subjects and patients with achromatopsia, CSNB1, and CSNB2. 61
21947599 2011
26
Contribution of post-receporal cells to the cone a-wave of the human electroretinogram in congenital stationary night blindness and autoimmune-like retinopathy. 61
20800609 2010
27
TRPM1 mutations are associated with the complete form of congenital stationary night blindness. 54
20300565 2010
28
TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness. 54
19896113 2009
29
Altered G-protein coupling in an mGluR6 point mutant associated with congenital stationary night blindness. 61
19666700 2009
30
Keratoconus associated with CSNB1. 61
21686588 2009
31
Keratoconus associated with congenital stationary night blindness type 1. 61
21686418 2009
32
Postreceptoral contributions to the light-adapted ERG of mice lacking b-waves. 61
18440505 2008
33
High susceptibility to experimental myopia in a mouse model with a retinal on pathway defect. 61
18235018 2008
34
Nystagmus characteristics in congenital stationary night blindness (CSNB). 61
18227204 2008
35
Clinical and genetic characterization of a Chinese family with CSNB1. 61
18188951 2008
36
Keratoconus associated with CSNB1. 61
17179126 2007
37
Nyctalopin is essential for synaptic transmission in the cone dominated zebrafish retina. 61
17004930 2006
38
CSNB1 in Chinese families associated with novel mutations in NYX. 61
16670814 2006
39
Mutations in GRM6 cause autosomal recessive congenital stationary night blindness with a distinctive scotopic 15-Hz flicker electroretinogram. 61
16249515 2005
40
[Molecular genetic study of congenital stationary night blindness]. 54
15584351 2004
41
Abnormalities of the scotopic threshold response correlated with gene mutation in X-linked retinoschisis and congenital stationary night blindness. 61
14661905 2003
42
A potential spontaneous rat model of X-linked congenital stationary night blindness. 61
12906122 2003
43
Identification of the gene and the mutation responsible for the mouse nob phenotype. 61
12506099 2003
44
Infantile and childhood retinal blindness: a molecular perspective (The Franceschetti Lecture). 54
12187427 2002
45
A distinctive form of congenital stationary night blindness with cone ON-pathway dysfunction. 61
11874764 2002
46
Complete form of X-linked congenital stationary night blindness: refined mapping and evidence of genetic homogeneity. 61
11172618 2001
47
Large-scale analysis of sequence tags in Xp11.4-11.3 and evaluation of candidate genes for X-linked ocular diseases. 61
14564067 2001
48
The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat protein. 61
11062472 2000
49
Physical mapping and exclusion of GPR34 as the causative gene for congenital stationary night blindness type 1. 61
10982042 2000
50
Localization of the mouse nob (no b-wave) gene to the centromeric region of the X chromosome. 61
10509675 1999

Variations for Night Blindness, Congenital Stationary, Type 1e

ClinVar genetic disease variations for Night Blindness, Congenital Stationary, Type 1e:

6 (show top 50) (show all 185) ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎ ‎‎
# Gene Name Type Significance ClinVarId dbSNP ID GRCh37 Pos GRCh38 Pos
1 GPR179 NM_001004334.4(GPR179):c.779_780dup (p.Pro262fs)duplication Pathogenic 599074 rs1567728372 17:36498892-36498893 17:38343009-38343010
2 GPR179 NM_001004334.4(GPR179):c.1807C>T (p.His603Tyr)SNV Pathogenic 31200 rs281875234 17:36489899-36489899 17:38334016-38334016
3 GPR179 NM_001004334.4(GPR179):c.278del (p.Pro93fs)deletion Pathogenic 31201 rs794726685 17:36499395-36499395 17:38343512-38343512
4 GPR179 NM_001004334.4(GPR179):c.598C>T (p.Arg200Ter)SNV Pathogenic 31202 rs387907138 17:36499075-36499075 17:38343192-38343192
5 GPR179 NM_001004334.4(GPR179):c.1784+1G>ASNV Pathogenic 31203 rs773126191 17:36490586-36490586 17:38334703-38334703
6 GPR179 NM_001004334.4(GPR179):c.187del (p.Leu63fs)deletion Pathogenic 31205 rs794726686 17:36499486-36499486 17:38343603-38343603
7 GPR179 NM_001004334.4(GPR179):c.659A>G (p.Tyr220Cys)SNV Pathogenic 31206 rs281875236 17:36499014-36499014 17:38343131-38343131
8 GPR179 NM_001004334.4(GPR179):c.1727del (p.Tyr576fs)deletion Likely pathogenic 623175 rs1567725425 17:36490644-36490644 17:38334761-38334761
9 GPR179 NM_001004334.4(GPR179):c.5606A>C (p.Gln1869Pro)SNV Conflicting interpretations of pathogenicity 522291 rs201516786 17:36483846-36483846 17:38327963-38327963
10 GPR179 NM_001004334.4(GPR179):c.984del (p.Ser329fs)deletion Conflicting interpretations of pathogenicity 31204 rs770066665 17:36493523-36493523 17:38337640-38337640
11 GPR179 NM_001004334.4(GPR179):c.959G>A (p.Arg320Gln)SNV Conflicting interpretations of pathogenicity 196293 rs189931659 17:36493548-36493548 17:38337665-38337665
12 GPR179 NM_001004334.4(GPR179):c.4306C>T (p.Arg1436Trp)SNV Conflicting interpretations of pathogenicity 322986 rs147966258 17:36485146-36485146 17:38329263-38329263
13 GPR179 NM_001004334.4(GPR179):c.5975G>A (p.Gly1992Asp)SNV Conflicting interpretations of pathogenicity 322975 rs200936863 17:36483477-36483477 17:38327594-38327594
14 GPR179 NM_001004334.4(GPR179):c.5927G>A (p.Arg1976His)SNV Uncertain significance 322977 rs200274687 17:36483525-36483525 17:38327642-38327642
15 GPR179 NM_001004334.4(GPR179):c.3900A>T (p.Ile1300=)SNV Uncertain significance 322989 rs200167781 17:36485552-36485552 17:38329669-38329669
16 GPR179 NM_001004334.4(GPR179):c.3656_3657del (p.Pro1219fs)deletion Uncertain significance 322995 rs779266036 17:36485795-36485796 17:38329912-38329913
17 GPR179 NM_001004334.4(GPR179):c.2895G>A (p.Leu965=)SNV Uncertain significance 323006 rs200583958 17:36486557-36486557 17:38330674-38330674
18 GPR179 NM_001004334.4(GPR179):c.2809G>A (p.Val937Ile)SNV Uncertain significance 323007 rs765764314 17:36486643-36486643 17:38330760-38330760
19 GPR179 NM_001004334.4(GPR179):c.1784+9G>ASNV Uncertain significance 323016 rs774545222 17:36490578-36490578 17:38334695-38334695
20 GPR179 NM_001004334.4(GPR179):c.1723C>T (p.Arg575Cys)SNV Uncertain significance 323018 rs200801090 17:36490648-36490648 17:38334765-38334765
21 GPR179 NM_001004334.4(GPR179):c.1589G>A (p.Ser530Asn)SNV Uncertain significance 323020 rs371905233 17:36490972-36490972 17:38335089-38335089
22 GPR179 NM_001004334.4(GPR179):c.1417C>T (p.Leu473=)SNV Uncertain significance 323021 rs762389933 17:36491144-36491144 17:38335261-38335261
23 GPR179 NM_001004334.4(GPR179):c.1388T>A (p.Ile463Asn)SNV Uncertain significance 323022 rs886052897 17:36491492-36491492 17:38335609-38335609
24 GPR179 NM_001004334.4(GPR179):c.973G>A (p.Gly325Arg)SNV Uncertain significance 323027 rs200392643 17:36493534-36493534 17:38337651-38337651
25 GPR179 NM_001004334.4(GPR179):c.522C>T (p.Ile174=)SNV Uncertain significance 323038 rs377062748 17:36499151-36499151 17:38343268-38343268
26 GPR179 NM_001004334.4(GPR179):c.6351G>A (p.Trp2117Ter)SNV Uncertain significance 322970 rs766582295 17:36483101-36483101 17:38327218-38327218
27 GPR179 NM_001004334.4(GPR179):c.3806C>T (p.Thr1269Met)SNV Uncertain significance 322992 rs754266923 17:36485646-36485646 17:38329763-38329763
28 GPR179 NM_001004334.4(GPR179):c.*304A>GSNV Uncertain significance 322962 rs541537671 17:36482044-36482044 17:38326161-38326161
29 GPR179 NM_001004334.4(GPR179):c.4888G>A (p.Glu1630Lys)SNV Uncertain significance 322983 rs149998444 17:36484564-36484564 17:38328681-38328681
30 GPR179 NM_001004334.4(GPR179):c.3518G>C (p.Ser1173Thr)SNV Uncertain significance 322997 rs565610587 17:36485934-36485934 17:38330051-38330051
31 GPR179 NM_001004334.4(GPR179):c.3474C>A (p.Asn1158Lys)SNV Uncertain significance 322998 rs755044433 17:36485978-36485978 17:38330095-38330095
32 GPR179 NM_001004334.4(GPR179):c.2248T>A (p.Ser750Thr)SNV Uncertain significance 323012 rs772088402 17:36487204-36487204 17:38331321-38331321
33 GPR179 NM_001004334.4(GPR179):c.1784+8C>TSNV Uncertain significance 323017 rs137860025 17:36490579-36490579 17:38334696-38334696
34 GPR179 NM_001004334.4(GPR179):c.1217G>A (p.Arg406His)SNV Uncertain significance 323023 rs770208418 17:36492871-36492871 17:38336988-38336988
35 GPR179 NM_001004334.4(GPR179):c.1070T>C (p.Leu357Pro)SNV Uncertain significance 323024 rs747110718 17:36493018-36493018 17:38337135-38337135
36 GPR179 NM_001004334.4(GPR179):c.98G>A (p.Arg33His)SNV Uncertain significance 323042 rs886052900 17:36499575-36499575 17:38343692-38343692
37 GPR179 NM_001004334.4(GPR179):c.*824G>ASNV Uncertain significance 322954 rs191828655 17:36481524-36481524 17:38325641-38325641
38 GPR179 NM_001004334.4(GPR179):c.*516T>CSNV Uncertain significance 322958 rs886052893 17:36481832-36481832 17:38325949-38325949
39 GPR179 NM_001004334.4(GPR179):c.7035C>T (p.Gly2345=)SNV Uncertain significance 322964 rs368426715 17:36482417-36482417 17:38326534-38326534
40 GPR179 NM_001004334.4(GPR179):c.6965C>T (p.Thr2322Ile)SNV Uncertain significance 322965 rs759484427 17:36482487-36482487 17:38326604-38326604
41 GPR179 NM_001004334.4(GPR179):c.6621C>T (p.Ser2207=)SNV Uncertain significance 322968 rs781391422 17:36482831-36482831 17:38326948-38326948
42 GPR179 NM_001004334.4(GPR179):c.6012T>A (p.Asp2004Glu)SNV Uncertain significance 322973 rs886052895 17:36483440-36483440 17:38327557-38327557
43 GPR179 NM_001004334.4(GPR179):c.3919C>T (p.Arg1307Trp)SNV Uncertain significance 322988 rs765046358 17:36485533-36485533 17:38329650-38329650
44 GPR179 NM_001004334.4(GPR179):c.3357G>A (p.Ala1119=)SNV Uncertain significance 323001 rs547577586 17:36486095-36486095 17:38330212-38330212
45 GPR179 NM_001004334.4(GPR179):c.5774T>G (p.Phe1925Cys)SNV Uncertain significance 322978 rs770905475 17:36483678-36483678 17:38327795-38327795
46 GPR179 NM_001004334.4(GPR179):c.5083G>A (p.Glu1695Lys)SNV Uncertain significance 322981 rs199697891 17:36484369-36484369 17:38328486-38328486
47 GPR179 NM_001004334.4(GPR179):c.2556C>T (p.Leu852=)SNV Uncertain significance 323010 rs777488974 17:36486896-36486896 17:38331013-38331013
48 GPR179 NM_001004334.4(GPR179):c.989G>T (p.Gly330Val)SNV Uncertain significance 323026 rs372908857 17:36493518-36493518 17:38337635-38337635
49 GPR179 NM_001004334.4(GPR179):c.180C>T (p.Leu60=)SNV Uncertain significance 323040 rs770286670 17:36499493-36499493 17:38343610-38343610
50 GPR179 NM_001004334.4(GPR179):c.134G>T (p.Gly45Val)SNV Uncertain significance 323041 rs886052899 17:36499539-36499539 17:38343656-38343656

UniProtKB/Swiss-Prot genetic disease variations for Night Blindness, Congenital Stationary, Type 1e:

73
# Symbol AA change Variation ID SNP ID
1 GPR179 p.Asp126His VAR_067925 rs281875233
2 GPR179 p.Tyr220Cys VAR_067926 rs281875236
3 GPR179 p.Gly455Asp VAR_067927 rs281875235
4 GPR179 p.His603Tyr VAR_067928 rs281875234

Expression for Night Blindness, Congenital Stationary, Type 1e

Search GEO for disease gene expression data for Night Blindness, Congenital Stationary, Type 1e.

Pathways for Night Blindness, Congenital Stationary, Type 1e

GO Terms for Night Blindness, Congenital Stationary, Type 1e

Biological processes related to Night Blindness, Congenital Stationary, Type 1e according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 visual perception GO:0007601 8.8 NYX GPR179 CACNA1F

Sources for Night Blindness, Congenital Stationary, Type 1e

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....